|Bid||31.04 x 1000|
|Ask||31.05 x 1000|
|Day's range||30.62 - 31.74|
|52-week range||26.00 - 55.22|
|Beta (5Y monthly)||1.40|
|PE ratio (TTM)||N/A|
|Earnings date||27 Oct 2020 - 02 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||43.78|
Cardiovascular Systems (CSII) registers significant decline in STEMI activations in Q2 earnings as patients avoid hospitals.
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...
With me today are Scott Ward, CSI Chairman, President and Chief Executive Officer; Rhonda Robb, Operating Officer; Jeff Points, Chief Financial Officer; and Dr. Ryan Egeland, Chief Medical Officer. Approximately 30 minutes ago, we issued a press release announcing our full year and fiscal 2020 fourth quarter results.